Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q1 2026 · 10-Q
Revenue$391.76K$391.76K−23.2% vs Q1 2025 Net Income-$1.43M-$1.43MN/M vs Q1 2025 EPS Diluted-$0.75-$0.75N/M vs Q1 2025 Gross Profit$237,025−12.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flow-$485,291N/M Margins · derivedGross margin60.5%+7.6 pt vs Q1 2025
Operating margin-339.1%−43.9 pt vs Q1 2025
Net margin-365.5%−70.4 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end